FMR LLC 13D and 13G filings for Century Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 09:55 am Sale | 2024-11-08 | 13G | Century Therapeutics, Inc. IPSC | FMR LLC | 2,521,511 2.976% | -1,091,040 (-30.20%) | Filing |
| 2024-02-09 08:50 am Sale | 2024-02-08 | 13G | Century Therapeutics, Inc. IPSC | FMR LLC | 3,612,551 6.037% | -210,714 (-5.51%) | Filing |
| 2023-11-13 09:02 am Sale | 2023-11-10 | 13G | Century Therapeutics, Inc. IPSC | FMR LLC | 3,823,265 6.397% | -3,273,146 (-46.12%) | Filing |
| 2023-02-09 09:59 am Sale | 2023-02-09 | 13G | Century Therapeutics, Inc. IPSC | FMR LLC | 7,096,411 12.033% | -1,099,792 (-13.42%) | Filing |
| 2022-02-09 09:11 am Purchase | 2022-02-08 | 13G | Century Therapeutics, Inc. IPSC | FMR LLC | 8,196,203 14.999% | 943,642 (+13.01%) | Filing |
| 2021-08-10 10:33 am Purchase | 2021-08-09 | 13G | Century Therapeutics, Inc. IPSC | FMR LLC | 7,252,561 12.857% | 7,252,561 (New Position) | Filing |